Medical devices that could disrupt the healthcare field will be among the cutting-edge technologies to be revealed at the 18th annual MIXiii-Biomed Conference and Exhibition, May 14-16 in Tel Aviv.

More than 1,000 scientists, key opinion leaders, entrepreneurs and investors from 45 countries are expected to join 5,000 Israeli counterparts at the event.

Sessions will explore topics such as gene editing and gene therapy, artificial intelligence and digital health, personalized medicine, transformative cancer therapies, new kinds of cell therapies, and medical cannabis, in addition to disruptive devices.